A clinical trialon effectiveness of Ayurvedic medicines in improving the disease free survival and/or controlling recurrence of disease of breast cancer patients, who are carriers of BRCA 1/2 genes using complimentary Ayurvedic treatment.
Phase 2
- Conditions
- Health Condition 1: null- Health condition â??Breast and ovarian cancer patients carriers of BRCA ½ genes. Problem studied â??Early metastasis and rapid growth of cancer due to inherited susceptibility genesHealth Condition 2: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2017/01/007684
- Lead Sponsor
- Dr S P Sardeshmukh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Genetically predisposed patients (BRCA1/2 mutation carriers) with breast or ovarian cancer within 6 months to 1 year of diagnosis. During this period they would have completed conventional cancer treatment.Patients with stage I to IV of disease will be included
Exclusion Criteria
Patients with BRCA1/2 mutation reporting 1 year and more after diagnosis will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method